Related Experiment Videos
[Treatment of gonococcal urethritis].
K Osato1, C Katsukawa, M Makino
1Osaka Prefectural Bandai Clinic for STD.
The Japanese Journal of Antibiotics
|November 1, 1991
Summary
Levofloxacin (LVFX) and ofloxacin (OFLX) effectively treated gonococcal urethritis. Levofloxacin demonstrated superior antimicrobial activity against Neisseria gonorrhoeae strains, showing lower minimum inhibitory concentrations.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Gonococcal urethritis remains a significant public health concern, necessitating effective antimicrobial treatments.
- Ofloxacin (OFLX) is a widely used fluoroquinolone for treating Neisseria gonorrhoeae infections.
- Levofloxacin (LVFX), the L-isomer of ofloxacin, presents a potential alternative with possibly enhanced efficacy.
Purpose of the Study:
- To compare the clinical efficacy of levofloxacin (LVFX) versus ofloxacin (OFLX) in treating uncomplicated gonococcal urethritis.
- To evaluate the in vitro antimicrobial activity of LVFX and OFLX against clinical isolates of Neisseria gonorrhoeae.
Main Methods:
- A comparative study involving 5 male patients with uncomplicated gonococcal urethritis.
- Patients received either 300 mg/day of LVFX or 600 mg/day of OFLX for 5 days.
- Minimum inhibitory concentrations (MICs) of both drugs were determined against 57 Neisseria gonorrhoeae strains.
Main Results:
- Both levofloxacin and ofloxacin achieved excellent clinical outcomes in all treated patients.
- Levofloxacin exhibited significantly lower MICs compared to ofloxacin against the tested Neisseria gonorrhoeae strains.
- This suggests enhanced in vitro potency of LVFX over OFLX.
Conclusions:
- Levofloxacin is a highly effective treatment option for uncomplicated gonococcal urethritis.
- The lower MICs of levofloxacin indicate a potential for improved therapeutic outcomes and overcoming resistance.
- Further investigation into levofloxacin's role in managing gonorrhea is warranted.